Zyprexa

Feature Stories / Consumer issues / Business & Money / Health & Fitness

Life after Zyprexa: the Future of Eli Lilly and Company

The Indianapolis pharmaceutical company targets age-related ailments as U.S. patents on some of its most profitable drugs expire.

March 2012Evan WestAdd a comment
Health & Fitness / Consumer issues / Business & Money

Side Effects

The costly success of Zyprexa, Eli Lilly and Company’s top-selling antipsychotic drug.

October 2008Evan WestAdd a comment